Ipsen’s partner Exelixis announces clinical collaboration with Bristol Myers Squibb for late-stage combination trial in first-line renal cell carcinoma.

EACD 2020: How the use of functional assessments in clinical trials provides meaningful information for physicians treating children with cerebral palsy

Liver Cancer Awareness Month – Rethink liver cancer

Ipsen – Q3 2020 Sales Conference Call – Thursday, October 22, 2020

Ipsen announces sales growth over the first 9 months of 2020